Terms: = Liver cancer AND GPC3, OCI-5, 2719, ENSG00000147257, SGBS, SGB, DGSX, SDYS, P51654, AC002420_1, SGBS1 AND Diagnosis
171 results:
1. Extraction-free, immuno-RPA-CRISPR/Cas13a-based one-pot detection of glypican-3 directly from extracellular vesicles.
Xiao X; Lin X; Ting CL; Huang X; Zeng B; Liu T; Zeng T
Anal Chim Acta; 2024 Apr; 1297():342385. PubMed ID: 38438232
[TBL] [Abstract] [Full Text] [Related]
2. Aptamer-bivalent-cholesterol-mediated proximity entropy-driven exosomal protein reporter for tumor diagnosis.
Fan Z; Zhou J; Shu Q; Dong Y; Li Y; Zhang T; Bai G; Yu H; Lu F; Li J; Zhao X
Biosens Bioelectron; 2024 May; 251():116104. PubMed ID: 38368644
[TBL] [Abstract] [Full Text] [Related]
3. Combination of serum alpha-fetoprotein, PIVKA-Ⅱ and glypican-3 in diagnosis of hepatocellular carcinoma: a meta-analysis.
Song H; Wang J; Zhang H; Wu Y; Wang K; Wang X; Xu X
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2024 Feb; 53(1):131-139. PubMed ID: 38310085
[TBL] [Abstract] [Full Text] [Related]
4. WGCNA combined with machine learning to find potential biomarkers of liver cancer.
Lv JH; Hou AJ; Zhang SH; Dong JJ; Kuang HX; Yang L; Jiang H
Medicine (Baltimore); 2023 Dec; 102(50):e36536. PubMed ID: 38115320
[TBL] [Abstract] [Full Text] [Related]
5. Current methods for the detection of glypican-3.
Xiao X; Huang Q; Lin X; Zahid KR; Huang X; Liu T; Zeng T
Anal Methods; 2024 Jan; 16(2):152-160. PubMed ID: 38108085
[TBL] [Abstract] [Full Text] [Related]
6. Glutamine synthetase and hepatocellular carcinoma.
Jiang J; Hu Y; Fang D; Luo J
Clin Res Hepatol Gastroenterol; 2023 Dec; 47(10):102248. PubMed ID: 37979911
[TBL] [Abstract] [Full Text] [Related]
7. Whole-genome sequencing and RNA sequencing analysis reveals novel risk genes and differential expression patterns in hepatoblastoma.
Wang W; Zhang N; Chen L; Zhao X; Shan Y; Yang F; Wang B; Gao H; Xu M; Tang P; Qin S; Gu S
Gene; 2024 Mar; 897():147991. PubMed ID: 37972697
[TBL] [Abstract] [Full Text] [Related]
8. Kidney-type glutaminase is a biomarker for the diagnosis and prognosis of hepatocellular carcinoma: a prospective study.
Zhang L; Su K; Liu Q; Li B; Wang Y; Cheng C; Li Y; Xu C; Chen J; Wu H; Zhu M; Mai X; Cao Y; Peng J; Yue Y; Ding Y; Yu D
BMC Cancer; 2023 Nov; 23(1):1081. PubMed ID: 37946141
[TBL] [Abstract] [Full Text] [Related]
9. Predicting glypican-3 expression in hepatocellular carcinoma: A comprehensive analysis using combined contrast-enhanced ultrasound and clinical factors.
Li N; Dong T; Wang P; Li Q; Nie F
Clin Hemorheol Microcirc; 2023; 85(4):407-420. PubMed ID: 37638421
[TBL] [Abstract] [Full Text] [Related]
10. Clinicopathological features and differential diagnosis of gastric metastases.
Chen W; Liu C; Liu Y; Yuan J; Wang Z
World J Surg Oncol; 2023 Aug; 21(1):258. PubMed ID: 37608278
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic value of S100A4 and Glypican-3 in hepatocellular carcinoma in cirrhotic HCV patients.
El-Bendary M; Farid K; Arafa M; Elkashef W; Abdullah T; El-Mesery A
J Egypt Natl Canc Inst; 2023 Aug; 35(1):26. PubMed ID: 37599312
[TBL] [Abstract] [Full Text] [Related]
12. Orthogonally Engineered Albumin with Attenuated Macrophage Phagocytosis for the Targeted Visualization and Phototherapy of liver cancer.
Dou WT; Qiu P; Shi Y; Zhu L; Guo C; Li N; Zang Y; Liu T; Zhao S; Pan Y; Dong L; Sessler JL; Tan Y; Li J; Wang H; Tian H; He XP
J Am Chem Soc; 2023 Aug; 145(31):17377-17388. PubMed ID: 37497917
[TBL] [Abstract] [Full Text] [Related]
13. [The clinical value of serum gpc3 level in predicting recurrence of patients with primary hepatocellular carcinoma].
Zhang PR; Ma XL; Guo L; Lu RQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Jun; 57(6):885-890. PubMed ID: 37357208
[No Abstract] [Full Text] [Related]
14. A novel predictive model of microvascular invasion in hepatocellular carcinoma based on differential protein expression.
Wang Z; Cao L; Wang J; Wang H; Ma T; Yin Z; Cai W; Liu L; Liu T; Ma H; Zhang Y; Shen Z; Zheng H
BMC Gastroenterol; 2023 Mar; 23(1):89. PubMed ID: 36973651
[TBL] [Abstract] [Full Text] [Related]
15. H-rGO-Pd NPs Nanozyme Enhanced Silver Deposition Strategy for Electrochemical Detection of Glypican-3.
Li G; Wang B; Li L; Li X; Yan R; Liang J; Zhou X; Li L; Zhou Z
Molecules; 2023 Feb; 28(5):. PubMed ID: 36903516
[TBL] [Abstract] [Full Text] [Related]
16. Glypican-3, Vascular Endothelial Growth Factor and Golgi Protein-73 for Differentiation between liver Cirrhosis and Hepatocellular Carcinoma.
Mamdouh S; Soliman A; Khorshed F; Saber M
Asian Pac J Cancer Prev; 2023 Feb; 24(2):497-507. PubMed ID: 36853298
[TBL] [Abstract] [Full Text] [Related]
17. Enhanced glypican-3-targeted identification of hepatocellular carcinoma with liver fibrosis by pre-degrading excess fibrotic collagen.
Zhuo J; Wang Y; Hui H; Li C; Yang J; Zhang P; Fang C; Tian J
Acta Biomater; 2023 Mar; 158():435-448. PubMed ID: 36603729
[TBL] [Abstract] [Full Text] [Related]
18. A meta-analysis and of clinical values of 11 blood biomarkers, such as AFP, DCP, and GP73 for diagnosis of hepatocellular carcinoma.
Pang BY; Leng Y; Wang X; Wang YQ; Jiang LH
Ann Med; 2023 Dec; 55(1):42-61. PubMed ID: 36476015
[TBL] [Abstract] [Full Text] [Related]
19. Aptamer-mediated hollow MnO
Wang Z; Wu C; Liu J; Hu S; Yu J; Yin Q; Tian H; Ding Z; Qi G; Wang L; Hao L
Drug Deliv; 2023 Dec; 30(1):28-39. PubMed ID: 36457288
[TBL] [Abstract] [Full Text] [Related]
20. Custom gene expression panel for evaluation of potential molecular markers in hepatocellular carcinoma.
Pallerla SR; Hoan NX; Rachakonda S; Meyer CG; Van Tong H; Toan NL; Linh LTK; Giang DP; Kremsner PG; Bang MH; Song LH; Velavan TP
BMC Med Genomics; 2022 Nov; 15(1):235. PubMed ID: 36345011
[TBL] [Abstract] [Full Text] [Related]
[Next]
